You are here

Biocon Biologics

Jobevne (Bevacizumab) Gains FDA Nod, Biocon Expands US Oncology Biosimilars Portfolio

Xtalks

Sun, 04/13/25 - 11:15 pm

bevacizumab-nwgd

Biocon Biologics

FDA approves two biosimilars to blockbuster eye drug Eylea

Reuters

Mon, 05/20/24 - 11:23 am

Biocon Biologics

Samsung BioLogics

With J&J settlement, Biocon Biologics gets a license to challenge Stelara in the US

Fierce Pharma

Thu, 02/29/24 - 06:57 pm

Biocon Biologics